Relationship between blood glucose variability and microalbuminuria in type 2 diabetic patients with well-controlled glycosylated hemoglobin

National Medical Journal of China

Volumn 88, Issue 42, 2008, Pages 2977-2981

  Zhou, Jian ^a   Jia, Wei Ping ^a   Ma, Xiao Jing ^a   Bao, Yu Qian ^a   Lu, Wei ^a   Li, Ming ^a   Li, Qing ^a   Hu, Cheng ^a   Xiang, Kun San ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Albuminuria; Continuous glucose monitoring; Diabetes mellitus, type 2

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLYCOSYLATED HEMOGLOBIN;

ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE DURATION; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; MAJOR CLINICAL STUDY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; SYSTOLIC BLOOD PRESSURE; ADULT; AGED; ALBUMINURIA; BLOOD; BLOOD PRESSURE; FEMALE; MALE; METABOLISM; MIDDLE AGED; RISK FACTOR; TREATMENT OUTCOME; URINE;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME;

EID: 77954829599     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications, 2005, 19: 178-181.
2. Monnier L, Colette C. Glycemic variability: should we and can we prevent it? Diabetes Care, 2008, 31: S150-S154.
3. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, et al. Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia, 1989, 32: 219-226. (Pubitemid 19136363)
4. Service FJ, Molnar GD, Rosevear JW, et al. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes, 1970, 19: 644-655.
5. McDonnell CM, Donath SM, Vidmar SI, et al. A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther, 2005, 7: 253-263.
6. Selam JL. How to measure glycemic instability? Diabetes Metab, 2000, 26: 148-151.
7. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA, 2006, 295: 1681-1687.
8. Wentholt IM, Kulik W, Michels RP, et al. Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia, 2008, 51: 183-190.
9. Hirsch IB. Glycemic variability: it's not just about HbA1c anymore! Diabetes Technol Ther, 2005, 7: 780-783.
10. Risso A, Mercuri F, Quagliaro L, et al. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab, 2001, 281: E924-E930.
11. Takeuchi A, Throckmorton DC, Brogden AP, et al. Periodic high extracellular glucose enhances production of collagens III and IV by mesangial cells. Am J Physiol, 1995, 268: F13-F19. (Pubitemid 124005455)
12. Jones SC, Saunders HJ, Qi W, et al. Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells. Diabetologia, 1999, 42: 1113-1119.
13. Hirschberg Y, Karara AH, Pietri AO, et al. Improved control of mealtime glucose excursions with coadministration of nateglinide and metformin. Diabetes Care, 2000, 23: 349-353.
14. DeWitt DE, Hirsch IB. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA, 2003, 289: 2254-2264. (Pubitemid 37430194)